Kansai Nerolac Paints (500165) Q4 14/15 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 14/15 earnings summary
21 Oct, 2026Executive summary
FY15 sales and operating revenue ₹4,211.64 crore, up 12.6% YoY; PBT ₹398.90 crore, up 29.9%, and PAT ₹271.67 crore.
Performance benefited from procurement and operating-cost controls, lower interest expense, and a ₹9.6 crore net foreign-exchange gain included in other income.
Industrial and automotive coatings gained share; decorative growth initiatives included product launches, digital engagement, and expanded retail access through Flipkart.
Financial highlights
Net sales, net of excise and discounts, were ₹3,532.41 crore vs ₹3,145.77 crore; other income rose to ₹21.79 crore from ₹10.33 crore.
PBDIT excluding other income was ₹444.82 crore vs ₹362.09 crore, up 22.8%; PBT ₹398.90 crore vs ₹306.99 crore, up 29.9%.
PAT was ₹271.67 crore vs ₹206.57 crore; basic and diluted EPS ₹5.04 vs ₹3.83, restated for the share split.
Consolidated revenue from operations was ₹3,586.98 crore vs ₹3,193.28 crore; consolidated PAT after minority interest was ₹274.06 crore vs ₹207.96 crore.
Operating cash flow was ₹307.00 crore vs ₹189.22 crore; cash and cash equivalents ended FY15 at ₹34.05 crore vs ₹54.88 crore.
Outlook and guidance
Expected revival in housing, automotive, infrastructure, and smart-city investment could support demand across decorative, automotive, and performance coatings.
Lower crude and commodity prices eased cost pressure; falling inflation was expected to support consumer spending, while a poor farm-output outlook could dampen demand.
The FY16 budget announced an additional ₹70,000 crore of infrastructure investment over FY15, cited as a potential demand driver for paints.
Latest events from Kansai Nerolac Paints
- Cost control and cash generation offset pandemic-driven revenue decline and rising input costs.500165
Q4 20/21 - Cost controls lifted margins and PAT despite lower sales, as COVID-19 clouded the outlook.500165
Q4 19/20 - Revenue grew, profits eased, and acquisitions broadened the portfolio amid cost pressure.500165
Q4 18/19 - Sales and PBDIT advanced as capacity expansion met persistent cost pressures.500165
Q4 17/18 - Sales and operating profit grew as expansion advanced, offset by prior-year land-sale gains in PAT.500165
Q4 16/17 - Normalized profit advanced as growth plans expanded, while land-sale gains lifted reported earnings.500165
Q4 15/16 - An accounting write-back lifted reported FY13 profit as costs and currency weighed on outlook.500165
Q4 12/13 - Revenue grew 10.8%; capacity investment advanced as input costs and weak demand pressured results.500165
Q4 13/14 - 26.4% sales growth, higher PAT, but inflation and price pass-through constrained outlook.500165
Q4 10/11